Patents Not 'Limiting Factor' For Vaccine Production: BioNTech
- Order Reprints
- Print Article
German firm BioNTech said Thursday that patent protection for Covid-19 vaccines is not holding back production or supply of the jabs that it dev...
Already a Barron's subscriber? Sign In